img

Global Phosphodiesterase (PDE) inhibitors Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Phosphodiesterase (PDE) inhibitors Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s).
Phosphodiesterase (PDE) inhibitors report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Phosphodiesterase (PDE) inhibitors market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oral and Topical are the major drivers for the industry.
PDE inhibitor drugs are also used to treat various other medical conditions such as autoimmune indications, ulcerative colitis, and others. However, the increasing incidence of ED across the world will boost the global phosphodiesterase inhibitors market growth during the forecast period.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Phosphodiesterase (PDE) inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bayer AG
Eli Lilly and Co.
GlaxoSmithKline Plc
Pfizer Inc.
Vivus Inc.
Segment by Type
PDE1 Selective Inhibitors
PDE2 Selective Inhibitors
PDE3 Selective Inhibitors
PDE4 selective inhibitors
PDE5 selective inhibitors
PDE7 selective inhibitors
PDE10 selective inhibitors

Segment by Application


Oral
Topical
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Phosphodiesterase (PDE) inhibitors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Phosphodiesterase (PDE) inhibitors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Phosphodiesterase (PDE) inhibitors industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Phosphodiesterase (PDE) inhibitors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Phosphodiesterase (PDE) inhibitors introduction, etc. Phosphodiesterase (PDE) inhibitors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Phosphodiesterase (PDE) inhibitors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Phosphodiesterase (PDE) inhibitors Market Overview
1.1 Phosphodiesterase (PDE) inhibitors Product Overview
1.2 Phosphodiesterase (PDE) inhibitors Market Segment by Type
1.2.1 PDE1 Selective Inhibitors
1.2.2 PDE2 Selective Inhibitors
1.2.3 PDE3 Selective Inhibitors
1.2.4 PDE4 selective inhibitors
1.2.5 PDE5 selective inhibitors
1.2.6 PDE7 selective inhibitors
1.2.7 PDE10 selective inhibitors
1.3 Global Phosphodiesterase (PDE) inhibitors Market Size by Type
1.3.1 Global Phosphodiesterase (PDE) inhibitors Market Size Overview by Type (2024-2034)
1.3.2 Global Phosphodiesterase (PDE) inhibitors Historic Market Size Review by Type (2024-2024)
1.3.3 Global Phosphodiesterase (PDE) inhibitors Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2024-2024)
1.4.2 Europe Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Breakdown by Type (2024-2024)
2 Global Phosphodiesterase (PDE) inhibitors Market Competition by Company
2.1 Global Top Players by Phosphodiesterase (PDE) inhibitors Sales (2024-2024)
2.2 Global Top Players by Phosphodiesterase (PDE) inhibitors Revenue (2024-2024)
2.3 Global Top Players by Phosphodiesterase (PDE) inhibitors Price (2024-2024)
2.4 Global Top Manufacturers Phosphodiesterase (PDE) inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Phosphodiesterase (PDE) inhibitors Market Competitive Situation and Trends
2.5.1 Phosphodiesterase (PDE) inhibitors Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Phosphodiesterase (PDE) inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Phosphodiesterase (PDE) inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into Phosphodiesterase (PDE) inhibitors Market
2.8 Key Manufacturers Phosphodiesterase (PDE) inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Phosphodiesterase (PDE) inhibitors Status and Outlook by Region
3.1 Global Phosphodiesterase (PDE) inhibitors Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Phosphodiesterase (PDE) inhibitors Historic Market Size by Region
3.2.1 Global Phosphodiesterase (PDE) inhibitors Sales in Volume by Region (2024-2024)
3.2.2 Global Phosphodiesterase (PDE) inhibitors Sales in Value by Region (2024-2024)
3.2.3 Global Phosphodiesterase (PDE) inhibitors Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Phosphodiesterase (PDE) inhibitors Forecasted Market Size by Region
3.3.1 Global Phosphodiesterase (PDE) inhibitors Sales in Volume by Region (2024-2034)
3.3.2 Global Phosphodiesterase (PDE) inhibitors Sales in Value by Region (2024-2034)
3.3.3 Global Phosphodiesterase (PDE) inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Phosphodiesterase (PDE) inhibitors by Application
4.1 Phosphodiesterase (PDE) inhibitors Market Segment by Application
4.1.1 Oral
4.1.2 Topical
4.1.3 Other
4.2 Global Phosphodiesterase (PDE) inhibitors Market Size by Application
4.2.1 Global Phosphodiesterase (PDE) inhibitors Market Size Overview by Application (2024-2034)
4.2.2 Global Phosphodiesterase (PDE) inhibitors Historic Market Size Review by Application (2024-2024)
4.2.3 Global Phosphodiesterase (PDE) inhibitors Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2024-2024)
4.3.2 Europe Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Breakdown by Application (2024-2024)
5 North America Phosphodiesterase (PDE) inhibitors by Country
5.1 North America Phosphodiesterase (PDE) inhibitors Historic Market Size by Country
5.1.1 North America Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2024-2024)
5.1.3 North America Phosphodiesterase (PDE) inhibitors Sales in Value by Country (2024-2024)
5.2 North America Phosphodiesterase (PDE) inhibitors Forecasted Market Size by Country
5.2.1 North America Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2024-2034)
5.2.2 North America Phosphodiesterase (PDE) inhibitors Sales in Value by Country (2024-2034)
6 Europe Phosphodiesterase (PDE) inhibitors by Country
6.1 Europe Phosphodiesterase (PDE) inhibitors Historic Market Size by Country
6.1.1 Europe Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2024-2024)
6.1.3 Europe Phosphodiesterase (PDE) inhibitors Sales in Value by Country (2024-2024)
6.2 Europe Phosphodiesterase (PDE) inhibitors Forecasted Market Size by Country
6.2.1 Europe Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2024-2034)
6.2.2 Europe Phosphodiesterase (PDE) inhibitors Sales in Value by Country (2024-2034)
7 Asia-Pacific Phosphodiesterase (PDE) inhibitors by Region
7.1 Asia-Pacific Phosphodiesterase (PDE) inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Phosphodiesterase (PDE) inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales in Value by Region (2024-2034)
8 Latin America Phosphodiesterase (PDE) inhibitors by Country
8.1 Latin America Phosphodiesterase (PDE) inhibitors Historic Market Size by Country
8.1.1 Latin America Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2024-2024)
8.1.3 Latin America Phosphodiesterase (PDE) inhibitors Sales in Value by Country (2024-2024)
8.2 Latin America Phosphodiesterase (PDE) inhibitors Forecasted Market Size by Country
8.2.1 Latin America Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2024-2034)
8.2.2 Latin America Phosphodiesterase (PDE) inhibitors Sales in Value by Country (2024-2034)
9 Middle East and Africa Phosphodiesterase (PDE) inhibitors by Country
9.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bayer AG
10.1.1 Bayer AG Company Information
10.1.2 Bayer AG Introduction and Business Overview
10.1.3 Bayer AG Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Bayer AG Phosphodiesterase (PDE) inhibitors Products Offered
10.1.5 Bayer AG Recent Development
10.2 Eli Lilly and Co.
10.2.1 Eli Lilly and Co. Company Information
10.2.2 Eli Lilly and Co. Introduction and Business Overview
10.2.3 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Products Offered
10.2.5 Eli Lilly and Co. Recent Development
10.3 GlaxoSmithKline Plc
10.3.1 GlaxoSmithKline Plc Company Information
10.3.2 GlaxoSmithKline Plc Introduction and Business Overview
10.3.3 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.3.4 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Products Offered
10.3.5 GlaxoSmithKline Plc Recent Development
10.4 Pfizer Inc.
10.4.1 Pfizer Inc. Company Information
10.4.2 Pfizer Inc. Introduction and Business Overview
10.4.3 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Products Offered
10.4.5 Pfizer Inc. Recent Development
10.5 Vivus Inc.
10.5.1 Vivus Inc. Company Information
10.5.2 Vivus Inc. Introduction and Business Overview
10.5.3 Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Vivus Inc. Phosphodiesterase (PDE) inhibitors Products Offered
10.5.5 Vivus Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Phosphodiesterase (PDE) inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Phosphodiesterase (PDE) inhibitors Industrial Chain Analysis
11.4 Phosphodiesterase (PDE) inhibitors Market Dynamics
11.4.1 Phosphodiesterase (PDE) inhibitors Industry Trends
11.4.2 Phosphodiesterase (PDE) inhibitors Market Drivers
11.4.3 Phosphodiesterase (PDE) inhibitors Market Challenges
11.4.4 Phosphodiesterase (PDE) inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Phosphodiesterase (PDE) inhibitors Distributors
12.3 Phosphodiesterase (PDE) inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of PDE1 Selective Inhibitors
Table 2. Major Company of PDE2 Selective Inhibitors
Table 3. Major Company of PDE3 Selective Inhibitors
Table 4. Major Company of PDE4 selective inhibitors
Table 5. Major Company of PDE5 selective inhibitors
Table 6. Major Company of PDE7 selective inhibitors
Table 7. Major Company of PDE10 selective inhibitors
Table 8. Global Phosphodiesterase (PDE) inhibitors Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 9. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2024-2024) & (K Liter)
Table 10. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type (2024-2024)
Table 11. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2024-2024) & (US& Million)
Table 12. Global Phosphodiesterase (PDE) inhibitors Market Share in Value by Type (2024-2024)
Table 13. Global Phosphodiesterase (PDE) inhibitors Price by Type (2024-2024) & (USD/Liter)
Table 14. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2024-2034) & (K Liter)
Table 15. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type (2024-2034)
Table 16. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2024-2034) & (US$ Million)
Table 17. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type (2024-2034)
Table 18. Global Phosphodiesterase (PDE) inhibitors Price by Type (2024-2034) & (USD/Liter)
Table 19. North America Phosphodiesterase (PDE) inhibitors Sales by Type (2024-2024) & (K Liter)
Table 20. North America Phosphodiesterase (PDE) inhibitors Sales by Type (2024-2024) & (US$ Million)
Table 21. Europe Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Type (2024-2024)
Table 22. Europe Phosphodiesterase (PDE) inhibitors Sales by Type (2024-2024) & (US$ Million)
Table 23. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Type (2024-2024)
Table 24. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Type (2024-2024) & (US$ Million)
Table 25. Latin America Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Type (2024-2024)
Table 26. Latin America Phosphodiesterase (PDE) inhibitors Sales by Type (2024-2024) & (US$ Million)
Table 27. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales (K Liter) by Type (2024-2024)
Table 28. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Type (2024-2024) & (US$ Million)
Table 29. Global Phosphodiesterase (PDE) inhibitors Sales by Company (2024-2024) & (K Liter)
Table 30. Global Phosphodiesterase (PDE) inhibitors Sales Share by Company (2024-2024)
Table 31. Global Phosphodiesterase (PDE) inhibitors Revenue by Company (2024-2024) & (US$ Million)
Table 32. Global Phosphodiesterase (PDE) inhibitors Revenue Share by Company (2024-2024)
Table 33. Global Market Phosphodiesterase (PDE) inhibitors Price by Company (2024-2024) & (USD/Liter)
Table 34. Global Phosphodiesterase (PDE) inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Phosphodiesterase (PDE) inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Phosphodiesterase (PDE) inhibitors as of 2022)
Table 37. Date of Key Manufacturers Enter into Phosphodiesterase (PDE) inhibitors Market
Table 38. Key Manufacturers Phosphodiesterase (PDE) inhibitors Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Phosphodiesterase (PDE) inhibitors Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 41. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2024-2024) & (K Liter)
Table 42. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Region (2024-2024)
Table 43. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2024-2024) & (US$ Million)
Table 44. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Region (2024-2024)
Table 45. Global Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2024-2024)
Table 46. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2024-2034) & (K Liter)
Table 47. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 48. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 49. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Region (2024-2034)
Table 50. Global Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2024-2034)
Table 51. Global Phosphodiesterase (PDE) inhibitors Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 52. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) & (K Liter)
Table 53. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application (2024-2024)
Table 54. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 55. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application (2024-2024)
Table 56. Global Phosphodiesterase (PDE) inhibitors Price by Application (2024-2024) & (USD/Liter)
Table 57. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2034) & (K Liter)
Table 58. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application (2024-2034)
Table 59. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2034) & (US$ Million)
Table 60. Global Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application (2024-2034)
Table 61. Global Phosphodiesterase (PDE) inhibitors Price by Application (2024-2034) & (USD/Liter)
Table 62. North America Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) (K Liter)
Table 63. North America Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 64. Europe Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) (K Liter)
Table 65. Europe Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 66. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) (K Liter)
Table 67. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 68. Latin America Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) (K Liter)
Table 69. Latin America Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 70. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) (K Liter)
Table 71. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 72. North America Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2024) & (K Liter)
Table 73. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Country (2024-2024)
Table 74. North America Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2024) & (US$ Million)
Table 75. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Country (2024-2024)
Table 76. North America Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2034) & (K Liter)
Table 77. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 78. North America Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 79. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Country (2024-2034)
Table 80. Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2024) & (K Liter)
Table 81. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Country (2024-2024)
Table 82. Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2024) & (US$ Million)
Table 83. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Country (2024-2024)
Table 84. Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2034) & (K Liter)
Table 85. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Region (2024-2024) & (K Liter)
Table 89. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Region (2024-2024)
Table 90. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Region (2024-2024) & (US$ Million)
Table 91. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Region (2024-2024)
Table 92. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Region (2024-2034) & (K Liter)
Table 93. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2024) & (K Liter)
Table 97. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Country (2024-2024)
Table 98. Latin America Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2024) & (US$ Million)
Table 99. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Country (2024-2024)
Table 100. Latin America Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2034) & (K Liter)
Table 101. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2024) & (K Liter)
Table 105. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Country (2024-2024)
Table 106. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2024) & (US$ Million)
Table 107. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Country (2024-2024)
Table 108. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2034) & (K Liter)
Table 109. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Country (2024-2034)
Table 112. Bayer AG Company Information
Table 113. Bayer AG Introduction and Business Overview
Table 114. Bayer AG Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2024-2024)
Table 115. Bayer AG Phosphodiesterase (PDE) inhibitors Product
Table 116. Bayer AG Recent Development
Table 117. Eli Lilly and Co. Company Information
Table 118. Eli Lilly and Co. Introduction and Business Overview
Table 119. Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2024-2024)
Table 120. Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Product
Table 121. Eli Lilly and Co. Recent Development
Table 122. GlaxoSmithKline Plc Company Information
Table 123. GlaxoSmithKline Plc Introduction and Business Overview
Table 124. GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2024-2024)
Table 125. GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Product
Table 126. GlaxoSmithKline Plc Recent Development
Table 127. Pfizer Inc. Company Information
Table 128. Pfizer Inc. Introduction and Business Overview
Table 129. Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2024-2024)
Table 130. Pfizer Inc. Phosphodiesterase (PDE) inhibitors Product
Table 131. Pfizer Inc. Recent Development
Table 132. Vivus Inc. Company Information
Table 133. Vivus Inc. Introduction and Business Overview
Table 134. Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales (K Liter), Revenue (Million USD), Price (USD/Liter) and Gross Margin (2024-2024)
Table 135. Vivus Inc. Phosphodiesterase (PDE) inhibitors Product
Table 136. Vivus Inc. Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Phosphodiesterase (PDE) inhibitors Market Trends
Table 140. Phosphodiesterase (PDE) inhibitors Market Drivers
Table 141. Phosphodiesterase (PDE) inhibitors Market Challenges
Table 142. Phosphodiesterase (PDE) inhibitors Market Restraints
Table 143. Phosphodiesterase (PDE) inhibitors Distributors List
Table 144. Phosphodiesterase (PDE) inhibitors Downstream Customers
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Phosphodiesterase (PDE) inhibitors Product Picture
Figure 2. Global Phosphodiesterase (PDE) inhibitors Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Phosphodiesterase (PDE) inhibitors Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Phosphodiesterase (PDE) inhibitors Sales Status and Outlook (2024-2034) & (K Liter)
Figure 5. Product Picture of PDE1 Selective Inhibitors
Figure 6. Global PDE1 Selective Inhibitors Sales YoY Growth (2024-2034) & (K Liter)
Figure 7. Product Picture of PDE2 Selective Inhibitors
Figure 8. Global PDE2 Selective Inhibitors Sales YoY Growth (2024-2034) & (K Liter)
Figure 9. Product Picture of PDE3 Selective Inhibitors
Figure 10. Global PDE3 Selective Inhibitors Sales YoY Growth (2024-2034) & (K Liter)
Figure 11. Product Picture of PDE4 selective inhibitors
Figure 12. Global PDE4 selective inhibitors Sales YoY Growth (2024-2034) & (K Liter)
Figure 13. Product Picture of PDE5 selective inhibitors
Figure 14. Global PDE5 selective inhibitors Sales YoY Growth (2024-2034) & (K Liter)
Figure 15. Product Picture of PDE7 selective inhibitors
Figure 16. Global PDE7 selective inhibitors Sales YoY Growth (2024-2034) & (K Liter)
Figure 17. Product Picture of PDE10 selective inhibitors
Figure 18. Global PDE10 selective inhibitors Sales YoY Growth (2024-2034) & (K Liter)
Figure 19. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2024-2034) & (US$ Million)
Figure 20. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type in 2022 & 2034
Figure 21. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type in 2022
Figure 22. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type in 2022
Figure 23. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type in 2022
Figure 24. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type in 2022
Figure 27. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type in 2022
Figure 28. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Phosphodiesterase (PDE) inhibitors Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Phosphodiesterase (PDE) inhibitors Revenue in 2022
Figure 33. Phosphodiesterase (PDE) inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 34. Product Picture of Oral
Figure 35. Global Oral Sales YoY Growth (2024-2034) & (K Liter)
Figure 36. Product Picture of Topical
Figure 37. Global Topical Sales YoY Growth (2024-2034) & (K Liter)
Figure 38. Product Picture of Other
Figure 39. Global Other Sales YoY Growth (2024-2034) & (K Liter)
Figure 40. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2024-2034) & (US$ Million)
Figure 41. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Application in 2022 & 2034
Figure 42. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application in 2022
Figure 43. North America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application in 2022
Figure 44. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application in 2022
Figure 45. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application in 2022
Figure 48. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Phosphodiesterase (PDE) inhibitors Manufacturing Cost Structure
Figure 53. Phosphodiesterase (PDE) inhibitors Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries